Description
Ozempic - the Holy Grail of weight loss or a Devil’s Bargain? This episode is more than a debate — it’s an epic showdown. Jillian takes on Karl and Spencer nadolsky, two obesity medicine doctors over Ozempic - the so-called ‘miracle drug’ that’s been lighting up the headlines and stirring up a storm of controversy. Both have been relentless in their critiques of her and her stance - and let’s just say they’re not pulling any punches. They’ve taken to social media, podcasts, and anyone who will listen to call out what they claim are her ‘misinformed’ views.
But today, it’s face-to-face. No hiding behind articles or sound bites. Join the conversation as we dive into the craze and the controversy surrounding this popular weight loss medication. Whether you're a healthcare professional, a patient, or simply curious, this video is for you. Get ready to have your questions answered and your concerns addressed. The Ozempic debate explodes in this video, and you won't want to miss it!
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Brace yourself as Megyn Kelly holds nothing back going scorched earth on Joe Scarborough and the left wing media for their staggering hypocrisy after relentlessly comparing Trump to Hitler, propagated the Russia Russia Russia hoax AGAIN on Tulsi Gabbard, and so much more. Then she digs in deeper...
Published 11/22/24
In this Keeping It Real Hot Take Jillian uncovers the pros and cons of telehealth medicine. Is it the future of healthcare or a risky shortcut? From the convenience of virtual appointments to the potential pitfalls of missed diagnoses and technical issues, we’re giving you everything you need to...
Published 11/19/24
In this Keeping It Real Hot Take Jillian uncovers the truth about digital therapeutics—are they the future of healthcare, or just overhyped apps? Discover the pros and cons of these evidence-based tools, from accessibility and personalized care to privacy concerns and tech barriers. Tune in to...
Published 11/14/24